Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 28 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

GERD-related laryngitis diagnosis differs between specialities

March's issue of the American Journal of Gastroenterology shows that there is a dichotomy in treatment dose, duration, and perceived patient response to therapy between ear, nose, and throat physicians, and gastroenterologists.

News image

fiogf49gjkf04

Ear, nose, and throat physicians often diagnose gastroesophageal reflux disease (GERD)-related laryngitis.

This diagnosis is made on the basis of symptoms and laryngeal signs.

Patients may be referred to gastroenterologists who contend that many such patients do not have reflux.

Dr Tasneem Ahmed and colleagues from Ohio assessed this practice pattern differences among physicians and gastroenterologists.

The research team evaluated the differences in relation to the diagnosis and treatment of patients with GERD-related laryngitis.

Separate surveys were specifically designed for physicians and gastroenterologists.

Many gastroenterologists perform pre-therapy tests with low sensitivity in GERD-related laryngitis
American Journal of Gastroenterology

The surveys assessed the percentage of patients diagnosed with GERD-related laryngitis, as well as dose and duration of therapy.

Treatment response, and other diagnostic options in nonresponders were also assessed.

The team randomly mailed surveys to the American Academy of Otolaryngology Head and Neck Surgery and the American Gastroenterological Association.

Of the total 4,000 surveys sent, 39% of the ear, nose, and throat physicians and 28% of gastroenterologists responded.

The researchers observed that most respondents were private practitioners.

From the ear, nose, and throat survey, the diagnosis was most commonly based on symptoms such as globus, or throat clearing, cough, and hoarseness.

The team found that the most useful signs were laryngeal erythema and edema reported by 70% of respondents.

Of the ear, nose, and throat physicians, 74% reported they made the diagnosis more on symptoms than on laryngeal signs.

These physicians initiated therapy most often with proton pump inhibitor (PPI) once daily for 2 months.

The team noted that gastroenterologists were divided on pre-therapy testing.

About 50% reporting testing with esophagogastro-duodenoscopy followed by pH monitoring prior to therapy.

The researchers observed that the remaining 50% reported treating empirically with PPI twice daily for 3 months.

Of the gastroenterologists, 70% reported treatment response of less than 60%.

However, 62% of ear, nose, and throat physicians reported a response rate of greater than 60%.

Dr Ahmed's team concluded, “Globus and throat clearing were considered the most useful symptoms in diagnosing GERD-related laryngitis for ear, nose, and throat physicians.”

“Laryngeal erythema and edema were considered the most useful signs for diagnosis and treatment of this condition by ear, nose, and throat physicians.”

“However, these symptoms and signs may represent the least specific markers for reflux.”

“Many gastroenterologists perform pre-therapy testing which has low sensitivity in GERD-related laryngitis.”

“There is a dichotomy in treatment dose, duration, and perceived patient response to therapy between the 2 specialists.”

“Our study highlights a need for cross communication and education between these 2 disciplines in understanding and treating GERD-related laryngitis better.”

Am J Gastroenterol 2006: 101(3): 470
14 March 2006

Go to top of page Email this page Email this page to a colleague

 28 May 2018 
Therapeutic strategies for HCV
 28 May 2018 
Mesalazine in ulcerative colitis
 28 May 2018 
Technology and management of digestive diseases
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Post‐operative complications in elderly IBD
 25 May 2018 
Colorectal cancer–specific mortality
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us